Evaluation of MDW for Early Detection of Sepsis, Clinical Validity
1 other identifier
observational
947
2 countries
2
Brief Summary
The purpose of this study is to confirm the clinical validity and the performance of the Monocyte Width Distribution (MDW) parameter to detect the development of sepsis in a prospective study of Emergency Department (ED) adults who have blood draw including Complete Blood Count with differential (CBC-DIFF) ordered upon presentation in a Spanish \& French hospital and to verify cut-off for Tri-potassium ethylenediaminetetraacetic acid (K3EDTA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2018
CompletedFirst Posted
Study publicly available on registry
July 17, 2018
CompletedStudy Start
First participant enrolled
August 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2019
CompletedNovember 22, 2019
November 1, 2019
12 months
July 6, 2018
November 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification of sepsis based on Sepsis-2 criteria
Determination of diagnostic accuracy based on Receiver Operating Characteristic Curves
Within 4 hours of presentation
Secondary Outcomes (1)
Identification of sepsis based on Sepsis-3 criteria
Within 4 hours of presentation
Interventions
Tests will be run to determine early identification of sepsis and added value of the combination of tests. Results will not be used to manage patients
Eligibility Criteria
All adults with suspicion of infection who present to the Emergency Department and for whom a CBC-DIFF is ordered upon presentation
You may qualify if:
- CBC-DIFF upon presentation
- Adults (18-89) of all races \& ethnicities
- Signed Informed Consent
You may not qualify if:
- Previously enrolled
- Incomplete Informed Consent
- Subject discharged \<4 hours from presentation
- PCT or CRP not performed per protocol
- Pregnancy
- Prisoners
- Subjects Under Custody or Guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
La Pitié-Salpétrière
Paris, 75651, France
Hospital Universitari Germans Trias I Pujol
Badalona, 08910, Spain
Related Publications (1)
Hausfater P, Robert Boter N, Morales Indiano C, Cancella de Abreu M, Marin AM, Pernet J, Quesada D, Castro I, Careaga D, Arock M, Tejidor L, Velly L. Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study. Crit Care. 2021 Jun 30;25(1):227. doi: 10.1186/s13054-021-03622-5.
PMID: 34193208DERIVED
Biospecimen
plasma samples from LPS to be stored frozen for subsequent testing for sepsis biomarkers
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Hausfater, MD
Groupe Hospitalier Pitié-Salpêtrière
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2018
First Posted
July 17, 2018
Study Start
August 8, 2018
Primary Completion
August 2, 2019
Study Completion
August 30, 2019
Last Updated
November 22, 2019
Record last verified: 2019-11